J&J Wants Rivals' Marketing Data In Omnicare FCA Row

Law360, Washington (November 10, 2011, 2:58 PM EST) -- Johnson & Johnson on Wednesday demanded to see documents on other pharmaceutical makers' marketing practices that are allegedly relevant to two whistleblower actions brought by Omnicare Inc. employees claiming J&J paid tens of millions of dollars in kickbacks to Omnicare that resulted in false Medicaid claims.

A former Omnicare pharmacist acting as qui tam relator, intervening states and the U.S. government allege in Massachusetts federal court that J&J paid Omnicare to disregard cheaper rival drugs and promote J&J products to nursing homes nationwide. The payments caused...
To view the full article, register now.